Heterotopic Ossification Prophylaxis in Knoxville, TN
Heelex in Knoxville, TN provides timely, evidence-based single-fraction radiation prophylaxis for heterotopic ossification following total hip arthroplasty and other high-risk orthopedic procedures. We coordinate directly with referring surgeons to meet the critical post-operative treatment window.
✓ Medicare & major plans accepted ✓ FDA-Cleared Therapy ✓ 15-Minute Visits
4.7 stars from 273 patients Physician-Reviewed
See If You're a Candidate
Same business day callbacks Mon–Fri. No referral required.
Request a Consultation.
A phone or in-person consult with our physician. We'll listen, walk you through whether this is a fit, and verify your insurance before treatment. Easy to start. No referral. No runaround.
Request a Call or Text
No referral required. Tell us a little about you and we'll reach back same business day.
Heterotopic Ossification: Clinical Overview
Heterotopic ossification (HO) is the formation of mature lamellar bone within soft tissues surrounding a joint, most commonly following total hip arthroplasty (THA). Clinically significant HO (Brooker Class III–IV) can result in pain, decreased range of motion, and functional impairment that may ultimately require revision surgery.
Established risk factors include a history of prior HO, hypertrophic osteoarthritis, ankylosing spondylitis, post-traumatic arthritis, male sex, and certain surgical approaches. In high-risk populations, the incidence of clinically significant HO without prophylaxis can exceed 30 percent.
Radiation Prophylaxis: Mechanism and Evidence
Single-fraction radiation therapy (typically 7–8 Gy) delivered within 72 hours of surgery — ideally within 24 hours either pre- or post-operatively — is a well-established prophylactic intervention. Radiation acts by disrupting the differentiation of mesenchymal progenitor cells into osteoblasts within the surgical field, thereby preventing the pathologic bone formation cascade.
Multiple randomized controlled trials and meta-analyses demonstrate that single-fraction radiation is equivalent in efficacy to fractionated regimens and comparable to NSAID prophylaxis, with the advantage of avoiding the gastrointestinal and wound-healing complications associated with prolonged NSAID use. Prophylactic radiation reduces the incidence of clinically significant HO to below 10 percent in most published series.
Referral Indications
Radiation prophylaxis for HO is indicated for patients undergoing:
- Total hip arthroplasty with established risk factors for HO
- Revision THA, particularly with prior HO
- Acetabular fracture fixation
- Elbow trauma surgery in high-risk patients
- Re-excision of existing heterotopic bone
The critical variable is timing. Treatment must be initiated within the 24- to 72-hour post-operative window to achieve maximum efficacy. Our clinic maintains scheduling capacity to accommodate urgent post-surgical referrals.
Referring to Heelex
Our Knoxville, TN facility is equipped to deliver single-fraction HO prophylaxis with rapid turnaround. The referral process is streamlined:
- Contact our clinic to initiate the referral and confirm scheduling availability relative to the planned surgical date.
- Provide operative details including procedure type, laterality, surgical approach, and relevant risk factors.
- Patient presents post-operatively within the agreed-upon window. Treatment is delivered in a single session lasting approximately 15 to 20 minutes.
- Documentation is returned to the referring surgeon promptly, including treatment summary and dose verification.
We understand the time-sensitive nature of HO prophylaxis and prioritize these cases accordingly.
Working With Your Surgeon
Your orthopedic surgeon knows your history and your options better than anyone. We don't replace them, and we wouldn't want to. We're a resource for them — for patients who are at risk of heterotopic ossification and want to lower that risk around surgery. You stay in their care: we treat only what's referred, keep your doctors informed, and refer you back to them. We're not here to take anyone's patients.
Scientific references
Mücke R, Schönekaes K, Micke O, Seegenschmiedt MH. (2003). Prophylactic radiotherapy for heterotopic ossification after total hip arthroplasty. Strahlentherapie und Onkologie.
Open on PubMedSeegenschmiedt MH, Micke O, Niewald M, et al. (2015). DEGRO guidelines for radiotherapy — heterotopic ossification prophylaxis. Strahlentherapie und Onkologie.
Open on PubMed
Frequently Asked Questions: Heterotopic Ossification & LDRT
Is radiation therapy safe for preventing heterotopic ossification? +
Yes. It is given as one short, low-dose treatment targeted to the area at risk, and the dose is a fraction of what is used to treat cancer. It has been used this way for decades to help prevent abnormal bone formation, and side effects are uncommon.
Does low-dose radiation therapy prevent heterotopic ossification? +
It is used to prevent abnormal bone from forming in soft tissue in people at high risk — most often around hip surgery or after certain injuries. Given close to the time of surgery, published studies show it lowers the chance of heterotopic ossification developing. It does not remove bone that has already formed, and individual results vary.
I'm at high risk for heterotopic ossification after hip surgery — what are my options? +
Preventive low-dose radiation therapy is one option, coordinated with your surgeon and given as a single treatment shortly before or after surgery. It is a brief, non-surgical step aimed at keeping the abnormal bone from forming in the first place.
Do I need a referral? +
No. You can call us directly. If you have an orthopedic surgeon, primary care physician, or rheumatologist, we coordinate with them.
Does it hurt? +
No. You feel nothing during treatment. No needle, no injection, no anesthesia.
Are there side effects? +
Rare. Some patients notice mild, temporary skin redness. No systemic side effects.
Will it cause cancer? +
The dose used for benign conditions is 10 to 25 times lower than the dose used to treat cancer. Long-term studies in Germany — where LDRT has been used for decades — have not shown an increased cancer risk at these low doses. We do not treat patients under 40 except in specific circumstances.
How quickly will I feel better? +
Most patients begin noticing relief between 6 and 12 weeks after their final session. About 70% report meaningful improvement.
How long does relief last? +
Typically 12 to 24 months. A second course can be given if symptoms return.
What if it doesn't work for me? +
Most patients respond well — and if your consultation shows you're not a strong candidate, we'll tell you up front, before you've spent a dime. LDRT also never closes any doors: every other option, including surgery, stays open to you.
Is it covered by insurance? +
Most major insurance is accepted, including Medicare and major commercial plans. Our office handles all insurance pre-authorization.
How many sessions will I need? +
Most benign musculoskeletal conditions require 6 to 8 weekday sessions, scheduled on consecutive business days so you complete a full course in under two weeks. Each session takes about 15 minutes. Some skin and fibrotic conditions follow different protocols — your consultation will clarify what fits your situation.
Is Low-Dose Radiation Therapy safe?
The dose used for benign conditions is a small fraction of cancer-treatment radiation — roughly 10–25× lower — delivered in a few short sessions. Low-dose radiation therapy for benign disease has decades of clinical use, and side effects are uncommon and typically mild.
Every treatment plan is prepared by a board-certified medical physicist and reviewed by a licensed physician. Whether it's the right option for you — and any personal considerations — is decided together during your consultation.